As of 2024-12-13, the Fair Value of Gritstone Oncology Inc (GRTS) is -7.41 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.03 USD, the upside of Gritstone Oncology Inc is -23,115.37%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -94.43 | -105.31 | -75.08 | -119.69 | -138.49 | -106.60 |
| YoY growth | -45.77% | -11.52% | 28.71% | -59.42% | -15.71% | -20.74% |
| Market Cap (mil) | 2.89 |
| P/E | |
| Forward P/E |
| EPS | -1.48 |
| Avg earnings growth rate | -20.74% |
| TTM earnings | -133.03 |